Robert Lang

2.1k total citations · 1 hit paper
28 papers, 1.6k citations indexed

About

Robert Lang is a scholar working on Oncology, Nephrology and Pathology and Forensic Medicine. According to data from OpenAlex, Robert Lang has authored 28 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Nephrology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Robert Lang's work include Bone health and treatments (11 papers), Parathyroid Disorders and Treatments (10 papers) and Vitamin D Research Studies (6 papers). Robert Lang is often cited by papers focused on Bone health and treatments (11 papers), Parathyroid Disorders and Treatments (10 papers) and Vitamin D Research Studies (6 papers). Robert Lang collaborates with scholars based in United States, Canada and Germany. Robert Lang's co-authors include Arthur E. Broadus, Ronald L. Horst, Leonard J. Deftos, E Cadman, Andrew F. Stewart, Ralph A. DeFronzo, Karl Insogna, Howard Rasmussen, A Ellison and Joseph M. Gertner and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and The American Journal of Medicine.

In The Last Decade

Robert Lang

27 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biochemical Evaluation of Patients with Cancer-Associated Hypercalcemia

1980 519 citations Andrew F. Stewart, Ronald L. Horst et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Lang United States	18	701	508	379	344	329	28	1.6k
C Nagant de Deuxchaisnes Belgium	21	643 0.9×	154 0.3×	168 0.4×	517 1.5×	449 1.4×	79	2.3k
D Scholz United States	17	302 0.4×	422 0.8×	241 0.6×	174 0.5×	177 0.5×	44	1.3k
V. Nunziata Italy	20	202 0.3×	193 0.4×	254 0.7×	168 0.5×	213 0.6×	29	931
D. Sudhaker Rao United States	22	480 0.7×	988 1.9×	128 0.3×	604 1.8×	240 0.7×	35	2.0k
Gianpaolo De Filippo Italy	22	336 0.5×	208 0.4×	346 0.9×	191 0.6×	357 1.1×	91	1.5k
Inga‐Lena Nilsson Sweden	23	396 0.6×	942 1.9×	212 0.6×	111 0.3×	303 0.9×	76	1.6k
Daniele Diacinti Italy	27	565 0.8×	700 1.4×	175 0.5×	953 2.8×	276 0.8×	74	2.0k
Johan Westerdahl Sweden	29	1.0k 1.4×	1.1k 2.1×	361 1.0×	146 0.4×	268 0.8×	53	2.7k
Kenichiro Kusano Japan	14	288 0.4×	1.1k 2.2×	205 0.5×	113 0.3×	513 1.6×	20	1.8k
Hanna Mawad United States	17	392 0.6×	986 1.9×	147 0.4×	449 1.3×	108 0.3×	23	1.2k

Countries citing papers authored by Robert Lang

Since Specialization

Citations

This map shows the geographic impact of Robert Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Lang more than expected).

Fields of papers citing papers by Robert Lang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Lang. The network helps show where Robert Lang may publish in the future.

Co-authorship network of co-authors of Robert Lang

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Lang. A scholar is included among the top collaborators of Robert Lang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Lang. Robert Lang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakchbandi, Inaam A., Robert Lang, Barbara K. Kinder, & Karl Insogna. (2007). The Role of the Receptor Activator of Nuclear Factor-κB Ligand/Osteoprotegerin Cytokine System in Primary Hyperparathyroidism. The Journal of Clinical Endocrinology & Metabolism. 93(3). 967–973. 26 indexed citations

Nakchbandi, Inaam A., Mary Ann Mitnick, Robert Lang, et al.. (2002). Circulating Levels of Interleukin-6 Soluble Receptor Predict Rates of Bone Loss in Patients with Primary Hyperparathyroidism. The Journal of Clinical Endocrinology & Metabolism. 87(11). 4946–4951. 36 indexed citations

Sarno, Manoel, David J. Baylink, Barbara L. Drinkwater, et al.. (2001). Excretion of Sweat and Urine Pyridinoline Crosslinks in Healthy Controls and Subjects with Established Metabolic Bone Disease. Clinical Chemistry and Laboratory Medicine (CCLM). 39(3). 223–8. 6 indexed citations

Siris, Ethel S., Arkadi Chines, Roy D. Altman, et al.. (1998). Risedronate in the Treatment of Paget's Disease of Bone: An Open Label, Multicenter Study. Journal of Bone and Mineral Research. 13(6). 1032–1038. 112 indexed citations

Lang, Robert, Martin Rosentritt, A Leibrock, Michaël Behr, & Gerhard Handel. (1998). Colour stability of provisional crown and bridge restoration materials. BDJ. 185(9). 468–471. 22 indexed citations

Lang, Robert, et al.. (1996). PC Windows Finite Element Modeling of Landfill Gas Flow. DigitalCommons - CalPoly (California State Polytechnic University). 1 indexed citations

McClung, Michael R., Bensen Wg, Michael A. Bolognese, et al.. (1996). Risedronate treatment of postmenopausal women with low bone mass: Preliminary data. Osteoporosis International. 6(S1). 257–257. 6 indexed citations

Insogna, Karl, et al.. (1989). Trichlormethiazide and Oral Phosphate Therapy in Patients with Absorptive Hypercalciuria. The Journal of Urology. 141(2). 269–273. 14 indexed citations

Lang, Robert, Agnès Vignery, & Pamela S. Jensen. (1986). Case report: Fibrogenesis imperfecta ossium with early onset: Observations after 20 years of illness. Bone. 7(4). 237–246. 13 indexed citations

10.

Broadus, A E, Karl Insogna, Robert Lang, A Ellison, & Barbara E. Dreyer. (1985). Evidence for Disordered Control of 1,25-Dihydroxyvitamin D Production in Absorptive Hypercalciuria. The Journal of Urology. 133(1). 150–150. 1 indexed citations

11.

Baron, Roland, Joseph M. Gertner, Robert Lang, & Agnès Vignery. (1984). Letters to the Editor: Response. Pediatric Research. 18(5). 497–497.

12.

Broadus, A E, Lawrence E. Mallette, R.L. Horst, et al.. (1983). A Detailed Evaluation of Oral Phosphate Therapy in Selected Patients With Primary Hyperparathyroidism*. The Journal of Clinical Endocrinology & Metabolism. 56(5). 953–961. 63 indexed citations

13.

Broadus, Arthur E., Robert Lang, & Alan S. Kliger. (1981). The Influence of Calcium Intake and the Status of Intestinal Calcium Absorption on the Diagnostic Utility of Measurements of 24-Hour Cyclic Adenosine 3′,5′- Monophosphate Excretion *. The Journal of Clinical Endocrinology & Metabolism. 52(6). 1085–1089. 18 indexed citations

14.

Jensen, Peter S., et al.. (1980). Assessment of bone mass in the radius by computed tomography. American Journal of Roentgenology. 134(2). 285–292. 18 indexed citations

15.

Kinder, Barbara K., Arthur E. Broadus, Robert Lang, & Howard Rasmussen. (1980). Diagnostic and Therapeutic Approaches to Primary Hyperparathyroidism. Surgical Clinics of North America. 60(5). 1285–1295. 1 indexed citations

16.

Stewart, Andrew F., Ronald L. Horst, Leonard J. Deftos, et al.. (1980). Biochemical Evaluation of Patients with Cancer-Associated Hypercalcemia. New England Journal of Medicine. 303(24). 1377–1383. 519 indexed citations breakdown →

17.

Rasmussen, Howard, Roland Baron, Arthur E. Broadus, et al.. (1980). 1,25(OH)2D3 is not the only D metabolite involved in the pathogenesis of osteomalacia. The American Journal of Medicine. 69(3). 360–368. 27 indexed citations

18.

Lang, Robert, et al.. (1977). Effect of Long-Term Calcitonin Therapy on the Clinical Course of Osteogenesis Imperfecta. The Journal of Clinical Endocrinology & Metabolism. 44(2). 346–355. 23 indexed citations

19.

Teitelbaum, Steven L., et al.. (1974). Bone collagen aggregation abnormalities in osteogenesis imperfecta. Calcified Tissue International. 17(1). 75–79. 26 indexed citations

20.

Lang, Robert, et al.. (1962). Practical crown and bridge prosthodontics. McGraw-Hill eBooks. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact